Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
This process may be repeated weekly or bi-weekly depending on skin needs, tolerance, and desired results
3 Treatment Although an extensive discussion of the treatment of atrial fibrillation is beyond the scope of this article, the following sections briefly present the management of common arrhythmic causes of palpitations in patients in the primary care setting
To guarantee your safety, let your healthcare provider know about all other medications you are taking
Immunohistochemical assay indicated positive GLP-1R staining at the membrane and intracellular levels in both chondrocytes and RAW 264.7 murine macrophage cell lines by immunofluorescence (Suppl
10.1096/fj.05-3718com 3 AgusD